A Phase 4 interventional study of menjugate and Men C conjugate vaccine in Pneumococcal Infections and Meningococcal Infections, sponsored by Public Health England. Completed at 2 sites in United Kingdom. Open to participants aged 7 Weeks to 11 Weeks, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-10-01.
Sponsored by Public Health England · Phase 4, Interventional, and Prevention
Among 12 studies in Pneumococcal Infections with a site in United Kingdom — 1 open to participants now, 1 under way, none of them phase 3. Pneumococcal Infections · United Kingdom.
Among the 12 studies in Pneumococcal Infections with a site in United Kingdom, this one is the 3rd largest by enrollment of the 10 interventional ones, is the only one that started in 2005, is one of 5 in phase 4, and was the 1st registered.
298 studies on the registry are indexed under Pneumococcal Infections; 26 are open to participants now.
This study's enrollment of 392 is close to the median of 373 across 253 interventional studies indexed under Pneumococcal Infections.
Browse Pneumococcal Infections studies →1 of the 12 studies in Pneumococcal Infections with a site in United Kingdom is open now, in 1 country. Each count lists the studies.
Of the 21 Pneumococcal Infections studies recruiting now, 4 (19%) set no upper age limit and 15 (71%) stop at 75 or younger; 14 take children under 18; 17 take healthy volunteers.
This study: 7 Weeks to 11 Weeks · all sexes · healthy volunteers too.
The full table on the hub →12 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 1 started in 2005.
Median enrollment 118 across the 10 interventional studies, 1,425 across the 2 observational. Of the 10 that completed or were terminated, 2 (20%) have results posted.
4 of 12 have an industry lead sponsor. The 5 most frequent:
Public Health England is the lead sponsor of 37 studies on the registry; none are open to participants now.
Public Health England has 4 studies filed under Pneumococcal Infections — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 12 studies in Pneumococcal Infections with a site in United Kingdom, from their registry updates:
Nothing recorded among them since 2026-09-25.
The purpose of the study is to evaluate the immune responses of UK infants after one or two doses of pneumococcal conjugate vaccine or one or two doses of three different types of meningococcal conjugate vaccine given at either two and three or two and four months of age.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Menjugate vaccine at 2 and 3 months
Biological: menjugate
Menjugate vaccine at 2 and 4 months
Biological: Men C conjugate vaccine
Neissvacc at 2 and 3 months
Biological: Men C conjugate
Neissvacc at 2 and 4 months
Biological: Men C Conjugate
Meningitec at 2 and 3 months
Biological: Men C conjugate
Meningitec at 2 and 4 months
Biological: Men C conjugate
men C conjugate vaccine
men C conjugate vaccine
men C conjugate vaccine
men C conjugate vaccine
men C conjugate vaccine
men C conjugate vaccine
Immunogenicity
SBA men C responses
Time frame: 3 months after last sample
The record gives a start of Apr 2005, a primary completion of Jan 2010 and a completion of Jan 2010. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Neisseria meningitidis group C (strain C11) oligosaccharide CRM-197 adipic acid conjugate
Public Health England